首页> 美国卫生研究院文献>Cancer Science >Use of a Local Immunotherapy as an Adjunctive Tool for the Generation of Human Monoclonal Antibodies from Regional Lymph Nodes of Colonic Cancer Patients
【2h】

Use of a Local Immunotherapy as an Adjunctive Tool for the Generation of Human Monoclonal Antibodies from Regional Lymph Nodes of Colonic Cancer Patients

机译:使用局部免疫疗法作为辅助工具从结肠癌患者的区域淋巴结中产生人单克隆抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human hybridomas were generated through the fusion of the human B‐lymphoblastoid cell line HO‐323 with the regional lymph node lymphocytes of colonic cancer patients who had received a local immunotherapy. A total of 353 hybridomas were obtained from 4 patients and 116 of these were found to secrete ≧ 100 ng/ml human immunoglobulin. The efficiency was remarkably high as compared with that from patients without the local immunotherapy. Further immunohistological examination showed that 5 hybridomas secreted IgM which selectively reacted with colonic cancers. The results indicate that local immunotherapy could be an adjunctive tool for the generation of highly potent human hybridomas through augmenting the host's immunity.
机译:人类杂交瘤是通过人类B-淋巴母细胞系HO-323与接受局部免疫疗法的结肠癌患者的区域淋巴结淋巴细胞融合而产生的。从4名患者中获得了总共353个杂交瘤,并且发现其中的116个分泌≥100 ng / ml的人免疫球蛋白。与没有局部免疫疗法的患者相比,该效率显着高。进一步的免疫组织学检查显示,有5个杂交瘤分泌IgM,这些IgM与结肠癌选择性反应。结果表明,局部免疫疗法可能是通过增强宿主免疫力来产生高效人杂交瘤的辅助工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号